ReSearch Pharmaceutical Services, a global clinical research organization (CRO) that provides trial management services to the biopharmaceutical industry, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Fort Washington, PA-based company, which was founded in 1994 and booked $239 million in sales for the 12 months ended March 31, plans to list on the NASDAQ under the symbol RPSE. Jefferies & Co. is the lead underwriter on the deal, for which pricing terms and timing were nto disclosed.
